Provision of over-encapsulated Sitagliptin (Januvia), Pioglitazone (Actos) and Cangliflozin (Invokana) for a double-blind randomised clinical trial
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the upper-middle of the Medical Equipment & Pharmaceuticals band — a substantial contract for the sector. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
The University of Exeter is seeking a suitable and capable provider of investigational medicinal product for use by its Medical School as part of a diabetes clinical trial.
The Unviersity of Exeter Medical School is undertaking a MRC-funded study aiming to develop a stratified approach in Type 2 diabetes that will result in more effective use of glucose lowering therapy.
The Trimaster trial, sponsored by the Royal Devon & Exeter NHS Foundation Trust (RD&E FT) is a randomised double-blind Cross-Over trial of three standard diabetes therapies, a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as third line therapy in 600 patients with type 2 diabetes.
It aims to directly test potential stratification by comparing a patient’s response (in terms of glycaemia, weight change, hypoglycaemia and patient reported outcomes) to these three glucose-lowering treatments.
Make the case to bid
Reveal who to approach at UNIVERSITY OF EXETER, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- 87e075f4-1490-404c-8edf-0a9a97dc8a8f
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- UOE/2015/042
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
UNIVERSITY OF EXETER’s tender network